Search Results 601-610 of 37895 for Two-phase

  1. Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL) - Mayo Clinic

    Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by Phase 3), parallel-arm study of avelumab in ...

  2. A Study Evaluating Efruxifermin in Subjects with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis - Mayo Clinic

    The purpose of this study is to evaluate efruxifermin (EFX) in subjects with non-cirrhotic NASH/MASH and fibrosis stage 2 or 3 (F2 or F3). Participation ...

  3. Kidney cancer - Diagnosis and treatment - Mayo Clinic

    Stage 2 kidney cancer. A stage 2 kidney cancer means that the tumor in the kidney is larger than 2 3/4 inches (7 centimeters) in diameter, but it's still ...

  4. Clinical trials - Oncology (Medical)

    This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...

  5. Hematology - Clinical trials

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...

  6. Publications - Garima Suman, M.D. - Mayo Clinic

    Two-stage deep learning model for fully automated pancreas segmentation on ... phase. Abdom Radiol (NY). 2020 Dec; 45(12):4302-4310. Epub 2020 Sep 16 ...

  7. Systemic Mastocytosis Clinical Trials - Mayo Clinic Research

    This is an open-label, two-part Phase 2 study investigating CGT9486 for the treatment of patients with Advanced Systemic Mastocytosis (AdvSM), including ...

  8. A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723) - Mayo Clinic

    This is an open-label, nonrandomized, Phase 1/2 study in subjects with advanced or metastatic solid tumors. Phase 1 is an assessment to evaluate the safety ...

  9. Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD) - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  10. Non Clinical Trials - Mayo Clinic Research

    The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma, (RR ...